Medifast, Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023
February 20, 2024 at 04:05 pm EST
Share
Medifast, Inc. reported earnings results for the fourth quarter ended December 31, 2023. For the fourth quarter, the company reported sales was USD 191.02 million compared to USD 337.25 million a year ago. Net income was USD 6.04 million compared to USD 26.52 million a year ago.
Basic earnings per share from continuing operations was USD 0.55 compared to USD 2.43 a year ago. Diluted earnings per share from continuing operations was USD 0.55 compared to USD 2.41 a year ago.
Medifast, Inc. is a health and wellness company. The Company provides a habit-based and coach-guided lifestyle solution OPTAVIA, which provides people with a comprehensive approach to help them achieve lasting optimal health and wellbeing. OPTAVIA's lifestyle plans deliver clinically proven health benefits as well as evidence-based tools, including scientifically developed products and a framework for habit creation reinforced by independent coaches and community support. Through a collaboration with the virtual primary care provider LifeMD, Inc (LifeMD), OPTAVIA customers have access to board-certified affiliated clinicians and medications, such as GLP-1s, that support treatment plans for obesity and other health conditions. OPTAVIA Coaches introduce customers to a set of healthy habits, and offer OPTAVIA-branded products, including Fuelings as well as OPTAVIA ACTIVE, a line of essential amino acid supplements and protein powders. Its operations are conducted through its subsidiaries.
MEDIFAST, INC. 
